Enhancing the Design and Evaluation of Care Delivery for Patients on Oral Anticancer Agents

J Natl Compr Canc Netw. 2022 Oct;20(10):1185-1187. doi: 10.6004/jnccn.2022.7076.
No abstract available

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents* / therapeutic use
  • Delivery of Health Care
  • Drug Delivery Systems
  • Humans
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents